Consequently, it is currently not possible to determine the correlation between adverse events experienced during the treatment period and subsequent weight regain after discontinuation
Some insurance plans require periodic reviews demonstrating continued treatment benefit, ongoing medical necessity, and weight loss progress
Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, et al
While more research is needed, current studies suggest that semaglutides anti-inflammatory properties could help relieve back pain, offering a potential new option for patients struggling with this condition
It is not a medicinal product, is not approved for use in humans or animals, and does not replace medical advice